世界各国のリアルタイムなデータ・インテリジェンスで皆様をお手伝い
αグルコシダーゼ阻害剤の世界市場成長 2024-2030Global Alpha Glucosidase Inhibitors Market Growth 2024-2030 α-グルコシダーゼは、α-グルコシダーゼ阻害薬によって阻害される酵素である。α-グルコシダーゼは、炭水化物をグルコースのような小さな糖分子に分解することにより、炭水化物の吸収を助ける。阻害は可逆的で、競... もっと見る
日本語のページは自動翻訳を利用し作成しています。 
サマリーα-グルコシダーゼは、α-グルコシダーゼ阻害薬によって阻害される酵素である。α-グルコシダーゼは、炭水化物をグルコースのような小さな糖分子に分解することにより、炭水化物の吸収を助ける。阻害は可逆的で、競合的阻害である。α-グルコシダーゼ阻害薬は、グルコースの吸収を遅らせ、炭水化物の消化を遅らせるのに役立つ。その結果、食後の血中グルコースの上昇が抑えられ、一日中効果が持続する。αグルコシダーゼ阻害剤の世界市場規模は、2023年の100万米ドルから2030年には100万米ドルに成長すると予測されており、2024年から2030年にかけて年平均成長率%で成長すると予測されている。 LPインフォメーション社の最新調査レポート「αグルコシダーゼ阻害剤産業予測」は、2023年のαグルコシダーゼ阻害剤の世界総売上高を過去の売上高と比較し、2024年から2030年までのαグルコシダーゼ阻害剤の売上高予測について地域別・市場分野別に包括的に分析しています。アルファグルコシダーゼ阻害剤の売上高を地域別、市場分野別、サブセクター別に分類し、世界のアルファグルコシダーゼ阻害剤産業の詳細な分析を百万米ドル単位で提供します。 本インサイトレポートでは、世界のαグルコシダーゼ阻害剤業界を包括的に分析し、製品区分、企業構成、売上高、市場シェア、最新動向、M&A活動に関する主要動向を明らかにします。また本レポートでは、αグルコシダーゼ阻害剤のポートフォリオと能力、市場参入戦略、市場での地位、地理的な足跡を中心に、世界の主要企業の戦略を分析し、加速する世界のαグルコシダーゼ阻害剤市場におけるこれらの企業の独自の地位をより深く理解しています。 この調査レポートは、αグルコシダーゼ阻害剤の世界的な見通しを形成する主要な市場動向、促進要因、影響要因を評価し、タイプ別、用途別、地域別、市場規模別に予測を細分化して、新たな機会のポケットを浮き彫りにします。何百ものボトムアップの定性的・定量的市場インプットに基づいた透明性の高い手法により、この調査予測は世界のαグルコシダーゼ阻害剤の現状と将来の軌道について非常にニュアンスのある見解を提供します。 アカルボースは、現在入手可能な3種類のα-グルコシダーゼ阻害剤（アカルボース、ミグリトール、ボグリボース）の中で最も広く処方されており、長年にわたり高血糖の管理に使用されている。 本レポートでは、製品タイプ、用途、主要メーカー、主要地域・国別のα-グルコシダーゼ阻害剤市場の包括的な概要、市場シェア、成長機会を紹介する。 タイプ別セグメント ダンピング症候群 2型糖尿病 用途別セグメント オンライン薬局 小売薬局 病院薬局 また、本レポートでは地域別に市場を分割しています： 南北アメリカ アメリカ カナダ メキシコ ブラジル APAC 中国 日本 韓国 東南アジア インド オーストラリア ヨーロッパ ドイツ フランス 英国 イタリア ロシア 中東・アフリカ エジプト 南アフリカ イスラエル トルコ GCC諸国 以下の企業は、主要な専門家から収集した情報、および企業のカバレッジ、製品ポートフォリオ、市場浸透度の分析に基づいて選択されています。 ファイザー バイエル薬品 武田薬品 サンファーマ グレンマーク トレント ヘキサラグ ユニケム 本レポートで扱う主な質問 世界のαグルコシダーゼ阻害剤市場の10年展望は？ αグルコシダーゼ阻害剤の世界市場および地域別市場成長の要因は何か？ 市場別、地域別に最も急成長する技術は何か？ αグルコシダーゼ阻害剤の市場機会は最終市場規模によってどのように異なるのか？ αグルコシダーゼ阻害剤のタイプ別、用途別内訳は？ 目次1 Scope of the Report1.1 Market Introduction 1.2 Years Considered 1.3 Research Objectives 1.4 Market Research Methodology 1.5 Research Process and Data Source 1.6 Economic Indicators 1.7 Currency Considered 1.8 Market Estimation Caveats 2 Executive Summary 2.1 World Market Overview 2.1.1 Global Alpha Glucosidase Inhibitors Annual Sales 2019-2030 2.1.2 World Current & Future Analysis for Alpha Glucosidase Inhibitors by Geographic Region, 2019, 2023 & 2030 2.1.3 World Current & Future Analysis for Alpha Glucosidase Inhibitors by Country/Region, 2019, 2023 & 2030 2.2 Alpha Glucosidase Inhibitors Segment by Type 2.2.1 Dumping Syndrome 2.2.2 Type 2 Diabetes 2.3 Alpha Glucosidase Inhibitors Sales by Type 2.3.1 Global Alpha Glucosidase Inhibitors Sales Market Share by Type (2019-2024) 2.3.2 Global Alpha Glucosidase Inhibitors Revenue and Market Share by Type (2019-2024) 2.3.3 Global Alpha Glucosidase Inhibitors Sale Price by Type (2019-2024) 2.4 Alpha Glucosidase Inhibitors Segment by Application 2.4.1 Online Pharmacies 2.4.2 Retail Pharmacies 2.4.3 Hospital Pharmacies 2.5 Alpha Glucosidase Inhibitors Sales by Application 2.5.1 Global Alpha Glucosidase Inhibitors Sale Market Share by Application (2019-2024) 2.5.2 Global Alpha Glucosidase Inhibitors Revenue and Market Share by Application (2019-2024) 2.5.3 Global Alpha Glucosidase Inhibitors Sale Price by Application (2019-2024) 3 Global Alpha Glucosidase Inhibitors by Company 3.1 Global Alpha Glucosidase Inhibitors Breakdown Data by Company 3.1.1 Global Alpha Glucosidase Inhibitors Annual Sales by Company (2019-2024) 3.1.2 Global Alpha Glucosidase Inhibitors Sales Market Share by Company (2019-2024) 3.2 Global Alpha Glucosidase Inhibitors Annual Revenue by Company (2019-2024) 3.2.1 Global Alpha Glucosidase Inhibitors Revenue by Company (2019-2024) 3.2.2 Global Alpha Glucosidase Inhibitors Revenue Market Share by Company (2019-2024) 3.3 Global Alpha Glucosidase Inhibitors Sale Price by Company 3.4 Key Manufacturers Alpha Glucosidase Inhibitors Producing Area Distribution, Sales Area, Product Type 3.4.1 Key Manufacturers Alpha Glucosidase Inhibitors Product Location Distribution 3.4.2 Players Alpha Glucosidase Inhibitors Products Offered 3.5 Market Concentration Rate Analysis 3.5.1 Competition Landscape Analysis 3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2024) 3.6 New Products and Potential Entrants 3.7 Mergers & Acquisitions, Expansion 4 World Historic Review for Alpha Glucosidase Inhibitors by Geographic Region 4.1 World Historic Alpha Glucosidase Inhibitors Market Size by Geographic Region (2019-2024) 4.1.1 Global Alpha Glucosidase Inhibitors Annual Sales by Geographic Region (2019-2024) 4.1.2 Global Alpha Glucosidase Inhibitors Annual Revenue by Geographic Region (2019-2024) 4.2 World Historic Alpha Glucosidase Inhibitors Market Size by Country/Region (2019-2024) 4.2.1 Global Alpha Glucosidase Inhibitors Annual Sales by Country/Region (2019-2024) 4.2.2 Global Alpha Glucosidase Inhibitors Annual Revenue by Country/Region (2019-2024) 4.3 Americas Alpha Glucosidase Inhibitors Sales Growth 4.4 APAC Alpha Glucosidase Inhibitors Sales Growth 4.5 Europe Alpha Glucosidase Inhibitors Sales Growth 4.6 Middle East & Africa Alpha Glucosidase Inhibitors Sales Growth 5 Americas 5.1 Americas Alpha Glucosidase Inhibitors Sales by Country 5.1.1 Americas Alpha Glucosidase Inhibitors Sales by Country (2019-2024) 5.1.2 Americas Alpha Glucosidase Inhibitors Revenue by Country (2019-2024) 5.2 Americas Alpha Glucosidase Inhibitors Sales by Type 5.3 Americas Alpha Glucosidase Inhibitors Sales by Application 5.4 United States 5.5 Canada 5.6 Mexico 5.7 Brazil 6 APAC 6.1 APAC Alpha Glucosidase Inhibitors Sales by Region 6.1.1 APAC Alpha Glucosidase Inhibitors Sales by Region (2019-2024) 6.1.2 APAC Alpha Glucosidase Inhibitors Revenue by Region (2019-2024) 6.2 APAC Alpha Glucosidase Inhibitors Sales by Type 6.3 APAC Alpha Glucosidase Inhibitors Sales by Application 6.4 China 6.5 Japan 6.6 South Korea 6.7 Southeast Asia 6.8 India 6.9 Australia 6.10 China Taiwan 7 Europe 7.1 Europe Alpha Glucosidase Inhibitors by Country 7.1.1 Europe Alpha Glucosidase Inhibitors Sales by Country (2019-2024) 7.1.2 Europe Alpha Glucosidase Inhibitors Revenue by Country (2019-2024) 7.2 Europe Alpha Glucosidase Inhibitors Sales by Type 7.3 Europe Alpha Glucosidase Inhibitors Sales by Application 7.4 Germany 7.5 France 7.6 UK 7.7 Italy 7.8 Russia 8 Middle East & Africa 8.1 Middle East & Africa Alpha Glucosidase Inhibitors by Country 8.1.1 Middle East & Africa Alpha Glucosidase Inhibitors Sales by Country (2019-2024) 8.1.2 Middle East & Africa Alpha Glucosidase Inhibitors Revenue by Country (2019-2024) 8.2 Middle East & Africa Alpha Glucosidase Inhibitors Sales by Type 8.3 Middle East & Africa Alpha Glucosidase Inhibitors Sales by Application 8.4 Egypt 8.5 South Africa 8.6 Israel 8.7 Turkey 8.8 GCC Countries 9 Market Drivers, Challenges and Trends 9.1 Market Drivers & Growth Opportunities 9.2 Market Challenges & Risks 9.3 Industry Trends 10 Manufacturing Cost Structure Analysis 10.1 Raw Material and Suppliers 10.2 Manufacturing Cost Structure Analysis of Alpha Glucosidase Inhibitors 10.3 Manufacturing Process Analysis of Alpha Glucosidase Inhibitors 10.4 Industry Chain Structure of Alpha Glucosidase Inhibitors 11 Marketing, Distributors and Customer 11.1 Sales Channel 11.1.1 Direct Channels 11.1.2 Indirect Channels 11.2 Alpha Glucosidase Inhibitors Distributors 11.3 Alpha Glucosidase Inhibitors Customer 12 World Forecast Review for Alpha Glucosidase Inhibitors by Geographic Region 12.1 Global Alpha Glucosidase Inhibitors Market Size Forecast by Region 12.1.1 Global Alpha Glucosidase Inhibitors Forecast by Region (2025-2030) 12.1.2 Global Alpha Glucosidase Inhibitors Annual Revenue Forecast by Region (2025-2030) 12.2 Americas Forecast by Country 12.3 APAC Forecast by Region 12.4 Europe Forecast by Country 12.5 Middle East & Africa Forecast by Country 12.6 Global Alpha Glucosidase Inhibitors Forecast by Type 12.7 Global Alpha Glucosidase Inhibitors Forecast by Application 13 Key Players Analysis 13.1 Pfizer 13.1.1 Pfizer Company Information 13.1.2 Pfizer Alpha Glucosidase Inhibitors Product Portfolios and Specifications 13.1.3 Pfizer Alpha Glucosidase Inhibitors Sales, Revenue, Price and Gross Margin (2019-2024) 13.1.4 Pfizer Main Business Overview 13.1.5 Pfizer Latest Developments 13.2 Bayer pharma 13.2.1 Bayer pharma Company Information 13.2.2 Bayer pharma Alpha Glucosidase Inhibitors Product Portfolios and Specifications 13.2.3 Bayer pharma Alpha Glucosidase Inhibitors Sales, Revenue, Price and Gross Margin (2019-2024) 13.2.4 Bayer pharma Main Business Overview 13.2.5 Bayer pharma Latest Developments 13.3 Takeda 13.3.1 Takeda Company Information 13.3.2 Takeda Alpha Glucosidase Inhibitors Product Portfolios and Specifications 13.3.3 Takeda Alpha Glucosidase Inhibitors Sales, Revenue, Price and Gross Margin (2019-2024) 13.3.4 Takeda Main Business Overview 13.3.5 Takeda Latest Developments 13.4 Sun pharma 13.4.1 Sun pharma Company Information 13.4.2 Sun pharma Alpha Glucosidase Inhibitors Product Portfolios and Specifications 13.4.3 Sun pharma Alpha Glucosidase Inhibitors Sales, Revenue, Price and Gross Margin (2019-2024) 13.4.4 Sun pharma Main Business Overview 13.4.5 Sun pharma Latest Developments 13.5 Glenmark pharma 13.5.1 Glenmark pharma Company Information 13.5.2 Glenmark pharma Alpha Glucosidase Inhibitors Product Portfolios and Specifications 13.5.3 Glenmark pharma Alpha Glucosidase Inhibitors Sales, Revenue, Price and Gross Margin (2019-2024) 13.5.4 Glenmark pharma Main Business Overview 13.5.5 Glenmark pharma Latest Developments 13.6 Torrent 13.6.1 Torrent Company Information 13.6.2 Torrent Alpha Glucosidase Inhibitors Product Portfolios and Specifications 13.6.3 Torrent Alpha Glucosidase Inhibitors Sales, Revenue, Price and Gross Margin (2019-2024) 13.6.4 Torrent Main Business Overview 13.6.5 Torrent Latest Developments 13.7 Hexalag 13.7.1 Hexalag Company Information 13.7.2 Hexalag Alpha Glucosidase Inhibitors Product Portfolios and Specifications 13.7.3 Hexalag Alpha Glucosidase Inhibitors Sales, Revenue, Price and Gross Margin (2019-2024) 13.7.4 Hexalag Main Business Overview 13.7.5 Hexalag Latest Developments 13.8 Unichem 13.8.1 Unichem Company Information 13.8.2 Unichem Alpha Glucosidase Inhibitors Product Portfolios and Specifications 13.8.3 Unichem Alpha Glucosidase Inhibitors Sales, Revenue, Price and Gross Margin (2019-2024) 13.8.4 Unichem Main Business Overview 13.8.5 Unichem Latest Developments 14 Research Findings and Conclusion
SummaryAlpha-glucosidase is an enzyme that is inhibited by alpha-glucosidase inhibitor drugs. Alpha-glucosidase helps in absorption of carbohydrates by breaking down carbohydrates into tiny sugar molecules such as glucose. The inhibition is reversible, and competitive inhibition. Alpha-glucosidase inhibitor drugs help in delaying glucose absorption and slow the digestion of carbohydrates. This results in lower rise of glucose in the blood after meals and remains effective throughout the day. Table of Contents1 Scope of the Report1.1 Market Introduction 1.2 Years Considered 1.3 Research Objectives 1.4 Market Research Methodology 1.5 Research Process and Data Source 1.6 Economic Indicators 1.7 Currency Considered 1.8 Market Estimation Caveats 2 Executive Summary 2.1 World Market Overview 2.1.1 Global Alpha Glucosidase Inhibitors Annual Sales 2019-2030 2.1.2 World Current & Future Analysis for Alpha Glucosidase Inhibitors by Geographic Region, 2019, 2023 & 2030 2.1.3 World Current & Future Analysis for Alpha Glucosidase Inhibitors by Country/Region, 2019, 2023 & 2030 2.2 Alpha Glucosidase Inhibitors Segment by Type 2.2.1 Dumping Syndrome 2.2.2 Type 2 Diabetes 2.3 Alpha Glucosidase Inhibitors Sales by Type 2.3.1 Global Alpha Glucosidase Inhibitors Sales Market Share by Type (2019-2024) 2.3.2 Global Alpha Glucosidase Inhibitors Revenue and Market Share by Type (2019-2024) 2.3.3 Global Alpha Glucosidase Inhibitors Sale Price by Type (2019-2024) 2.4 Alpha Glucosidase Inhibitors Segment by Application 2.4.1 Online Pharmacies 2.4.2 Retail Pharmacies 2.4.3 Hospital Pharmacies 2.5 Alpha Glucosidase Inhibitors Sales by Application 2.5.1 Global Alpha Glucosidase Inhibitors Sale Market Share by Application (2019-2024) 2.5.2 Global Alpha Glucosidase Inhibitors Revenue and Market Share by Application (2019-2024) 2.5.3 Global Alpha Glucosidase Inhibitors Sale Price by Application (2019-2024) 3 Global Alpha Glucosidase Inhibitors by Company 3.1 Global Alpha Glucosidase Inhibitors Breakdown Data by Company 3.1.1 Global Alpha Glucosidase Inhibitors Annual Sales by Company (2019-2024) 3.1.2 Global Alpha Glucosidase Inhibitors Sales Market Share by Company (2019-2024) 3.2 Global Alpha Glucosidase Inhibitors Annual Revenue by Company (2019-2024) 3.2.1 Global Alpha Glucosidase Inhibitors Revenue by Company (2019-2024) 3.2.2 Global Alpha Glucosidase Inhibitors Revenue Market Share by Company (2019-2024) 3.3 Global Alpha Glucosidase Inhibitors Sale Price by Company 3.4 Key Manufacturers Alpha Glucosidase Inhibitors Producing Area Distribution, Sales Area, Product Type 3.4.1 Key Manufacturers Alpha Glucosidase Inhibitors Product Location Distribution 3.4.2 Players Alpha Glucosidase Inhibitors Products Offered 3.5 Market Concentration Rate Analysis 3.5.1 Competition Landscape Analysis 3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2024) 3.6 New Products and Potential Entrants 3.7 Mergers & Acquisitions, Expansion 4 World Historic Review for Alpha Glucosidase Inhibitors by Geographic Region 4.1 World Historic Alpha Glucosidase Inhibitors Market Size by Geographic Region (2019-2024) 4.1.1 Global Alpha Glucosidase Inhibitors Annual Sales by Geographic Region (2019-2024) 4.1.2 Global Alpha Glucosidase Inhibitors Annual Revenue by Geographic Region (2019-2024) 4.2 World Historic Alpha Glucosidase Inhibitors Market Size by Country/Region (2019-2024) 4.2.1 Global Alpha Glucosidase Inhibitors Annual Sales by Country/Region (2019-2024) 4.2.2 Global Alpha Glucosidase Inhibitors Annual Revenue by Country/Region (2019-2024) 4.3 Americas Alpha Glucosidase Inhibitors Sales Growth 4.4 APAC Alpha Glucosidase Inhibitors Sales Growth 4.5 Europe Alpha Glucosidase Inhibitors Sales Growth 4.6 Middle East & Africa Alpha Glucosidase Inhibitors Sales Growth 5 Americas 5.1 Americas Alpha Glucosidase Inhibitors Sales by Country 5.1.1 Americas Alpha Glucosidase Inhibitors Sales by Country (2019-2024) 5.1.2 Americas Alpha Glucosidase Inhibitors Revenue by Country (2019-2024) 5.2 Americas Alpha Glucosidase Inhibitors Sales by Type 5.3 Americas Alpha Glucosidase Inhibitors Sales by Application 5.4 United States 5.5 Canada 5.6 Mexico 5.7 Brazil 6 APAC 6.1 APAC Alpha Glucosidase Inhibitors Sales by Region 6.1.1 APAC Alpha Glucosidase Inhibitors Sales by Region (2019-2024) 6.1.2 APAC Alpha Glucosidase Inhibitors Revenue by Region (2019-2024) 6.2 APAC Alpha Glucosidase Inhibitors Sales by Type 6.3 APAC Alpha Glucosidase Inhibitors Sales by Application 6.4 China 6.5 Japan 6.6 South Korea 6.7 Southeast Asia 6.8 India 6.9 Australia 6.10 China Taiwan 7 Europe 7.1 Europe Alpha Glucosidase Inhibitors by Country 7.1.1 Europe Alpha Glucosidase Inhibitors Sales by Country (2019-2024) 7.1.2 Europe Alpha Glucosidase Inhibitors Revenue by Country (2019-2024) 7.2 Europe Alpha Glucosidase Inhibitors Sales by Type 7.3 Europe Alpha Glucosidase Inhibitors Sales by Application 7.4 Germany 7.5 France 7.6 UK 7.7 Italy 7.8 Russia 8 Middle East & Africa 8.1 Middle East & Africa Alpha Glucosidase Inhibitors by Country 8.1.1 Middle East & Africa Alpha Glucosidase Inhibitors Sales by Country (2019-2024) 8.1.2 Middle East & Africa Alpha Glucosidase Inhibitors Revenue by Country (2019-2024) 8.2 Middle East & Africa Alpha Glucosidase Inhibitors Sales by Type 8.3 Middle East & Africa Alpha Glucosidase Inhibitors Sales by Application 8.4 Egypt 8.5 South Africa 8.6 Israel 8.7 Turkey 8.8 GCC Countries 9 Market Drivers, Challenges and Trends 9.1 Market Drivers & Growth Opportunities 9.2 Market Challenges & Risks 9.3 Industry Trends 10 Manufacturing Cost Structure Analysis 10.1 Raw Material and Suppliers 10.2 Manufacturing Cost Structure Analysis of Alpha Glucosidase Inhibitors 10.3 Manufacturing Process Analysis of Alpha Glucosidase Inhibitors 10.4 Industry Chain Structure of Alpha Glucosidase Inhibitors 11 Marketing, Distributors and Customer 11.1 Sales Channel 11.1.1 Direct Channels 11.1.2 Indirect Channels 11.2 Alpha Glucosidase Inhibitors Distributors 11.3 Alpha Glucosidase Inhibitors Customer 12 World Forecast Review for Alpha Glucosidase Inhibitors by Geographic Region 12.1 Global Alpha Glucosidase Inhibitors Market Size Forecast by Region 12.1.1 Global Alpha Glucosidase Inhibitors Forecast by Region (2025-2030) 12.1.2 Global Alpha Glucosidase Inhibitors Annual Revenue Forecast by Region (2025-2030) 12.2 Americas Forecast by Country 12.3 APAC Forecast by Region 12.4 Europe Forecast by Country 12.5 Middle East & Africa Forecast by Country 12.6 Global Alpha Glucosidase Inhibitors Forecast by Type 12.7 Global Alpha Glucosidase Inhibitors Forecast by Application 13 Key Players Analysis 13.1 Pfizer 13.1.1 Pfizer Company Information 13.1.2 Pfizer Alpha Glucosidase Inhibitors Product Portfolios and Specifications 13.1.3 Pfizer Alpha Glucosidase Inhibitors Sales, Revenue, Price and Gross Margin (2019-2024) 13.1.4 Pfizer Main Business Overview 13.1.5 Pfizer Latest Developments 13.2 Bayer pharma 13.2.1 Bayer pharma Company Information 13.2.2 Bayer pharma Alpha Glucosidase Inhibitors Product Portfolios and Specifications 13.2.3 Bayer pharma Alpha Glucosidase Inhibitors Sales, Revenue, Price and Gross Margin (2019-2024) 13.2.4 Bayer pharma Main Business Overview 13.2.5 Bayer pharma Latest Developments 13.3 Takeda 13.3.1 Takeda Company Information 13.3.2 Takeda Alpha Glucosidase Inhibitors Product Portfolios and Specifications 13.3.3 Takeda Alpha Glucosidase Inhibitors Sales, Revenue, Price and Gross Margin (2019-2024) 13.3.4 Takeda Main Business Overview 13.3.5 Takeda Latest Developments 13.4 Sun pharma 13.4.1 Sun pharma Company Information 13.4.2 Sun pharma Alpha Glucosidase Inhibitors Product Portfolios and Specifications 13.4.3 Sun pharma Alpha Glucosidase Inhibitors Sales, Revenue, Price and Gross Margin (2019-2024) 13.4.4 Sun pharma Main Business Overview 13.4.5 Sun pharma Latest Developments 13.5 Glenmark pharma 13.5.1 Glenmark pharma Company Information 13.5.2 Glenmark pharma Alpha Glucosidase Inhibitors Product Portfolios and Specifications 13.5.3 Glenmark pharma Alpha Glucosidase Inhibitors Sales, Revenue, Price and Gross Margin (2019-2024) 13.5.4 Glenmark pharma Main Business Overview 13.5.5 Glenmark pharma Latest Developments 13.6 Torrent 13.6.1 Torrent Company Information 13.6.2 Torrent Alpha Glucosidase Inhibitors Product Portfolios and Specifications 13.6.3 Torrent Alpha Glucosidase Inhibitors Sales, Revenue, Price and Gross Margin (2019-2024) 13.6.4 Torrent Main Business Overview 13.6.5 Torrent Latest Developments 13.7 Hexalag 13.7.1 Hexalag Company Information 13.7.2 Hexalag Alpha Glucosidase Inhibitors Product Portfolios and Specifications 13.7.3 Hexalag Alpha Glucosidase Inhibitors Sales, Revenue, Price and Gross Margin (2019-2024) 13.7.4 Hexalag Main Business Overview 13.7.5 Hexalag Latest Developments 13.8 Unichem 13.8.1 Unichem Company Information 13.8.2 Unichem Alpha Glucosidase Inhibitors Product Portfolios and Specifications 13.8.3 Unichem Alpha Glucosidase Inhibitors Sales, Revenue, Price and Gross Margin (2019-2024) 13.8.4 Unichem Main Business Overview 13.8.5 Unichem Latest Developments 14 Research Findings and Conclusion
ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。本レポートと同分野（医薬）の最新刊レポート
LP Information社の医薬品・ヘルスケア分野での最新刊レポート
本レポートと同じKEY WORD（inhibitors）の最新刊レポート
よくあるご質問LP Information社はどのような調査会社ですか?LP Informationは通信、エネルギー、医薬をはじめとする広範な市場の調査とレポート出版を行っている調査会社です。 もっと見る 調査レポートの納品までの日数はどの程度ですか?在庫のあるものは速納となりますが、平均的には 3-４日と見て下さい。
注文の手続きはどのようになっていますか?1)お客様からの御問い合わせをいただきます。
お支払方法の方法はどのようになっていますか?納品と同時にデータリソース社よりお客様へ請求書（必要に応じて納品書も）を発送いたします。
データリソース社はどのような会社ですか?当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
|
詳細検索
2024/12/26 10:27 158.43 円 165.15 円 201.51 円 |
